Biotech startups thrive in San Carlos nursery
Doug Crawford talks about how the biotech industry has largely been able to thrive amid the pandemic.
OneSkin launches topical senetherapeutic skin treatment
Symbiome, the first skincare brand to create a collection of BioIntact™ products to nourish the skin microbiome, has officially launched today.
Introducing Symbiome, the Future of Clean, Microbiome Skincare
Symbiome, the first skincare brand to create a collection of BioIntact™ products to nourish the skin microbiome, has officially launched today.
MBC BioLabs Congratulates Jennifer Doudna and Emmanuelle Charpentier on Receiving the 2020 Nobel Prize in Chemistry
Jennifer Doudna, also co-founder of Mammoth Biosciences, a MBC BioLabs alumni company, and Emmanuelle Charpentier are the first women to win a Nobel Prize in the sciences together.
Announcement of the Astellas Golden Ticket
EXTENDED! The competition is now open until Monday, November 2nd, 2020.
Siolta Therapeutics Raises $30M Series B for the Prevention and Treatment of Allergic Diseases
Siolta Therapeutics, a clinical-stage biotech company and MBC BioLabs San Carlos resident company, has raised $30M in a series B investment round to support the clinical development of its lead product, STMC-103H.
Announcement of the AMGEN Golden Ticket
Amgen and MBC BioLabs announced that BigHat Biosciences and Trilo Therapeutics have each been awarded an Amgen Golden Ticket to MBC BioLabs.
Symbiome Raises $15M for ‘Ancestral Microbiome’ Skin Range
Symbiome is slated to launch Oct. 7 with seven products that aim to shift the skin’s microbiome back to its “ancestral” state, according to Larry Weiss, founder and chief scientific officer.